1
Clinical Trials associated with Anti-Pseudomonas antibodies(University Hospital, Grenoble) / RecruitingNot ApplicableIIT Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies from B Lymphocytes of Patients Who Have Been Followed for Infection or Colonization with Pseudomonas Aeruginosa: a Prospective Monocentric Trial
Pseudomonas aeruginosa is a pathogenic bacteria for human, especially in hospital settings. It can sometimes be multi-resistant to many or even to all antibiotics usually used for its treatment.
The aim of the study is to isolate and produce therapeutic antibodies against the bacteria Pseudomonas aeruginosa in order to provide an alternative treatment to antibiotics in case of infection with an antibiotic-resistant strain of Pseudomonas aeruginosa.
100 Clinical Results associated with Anti-Pseudomonas antibodies(University Hospital, Grenoble)
100 Translational Medicine associated with Anti-Pseudomonas antibodies(University Hospital, Grenoble)
100 Patents (Medical) associated with Anti-Pseudomonas antibodies(University Hospital, Grenoble)
100 Deals associated with Anti-Pseudomonas antibodies(University Hospital, Grenoble)